Amrutanjan Health Care Ltd

Amrutanjan Health Care has announced its financial results for the quarter ending December 2024, highlighting significant achievements. The company reported its highest operating profit in five quarters at Rs 23.34 crore, with an operating profit margin of 19.01%. Profit after tax also reached a peak of Rs 19.25 crore, reflecting strong profitability.

Amrutanjan Health Care has recently experienced a revision in its score by MarketsMOJO, reflecting a shift in evaluation based on various financial metrics. Despite strong short-term growth indicators, concerns regarding long-term prospects and decreasing promoter confidence have influenced this adjustment. The stock remains on MarketsMOJO's list for further observation.

Amrutanjan Health Care, a smallcap pharmaceutical company, has reported a positive performance in the quarter ending September 2024. The company's financial score has improved significantly, with a growth in PBT and PAT. It has also announced a high dividend per share, indicating a strong financial position and potential for growth in the industry.

Amrutanjan Health Care, a smallcap pharmaceutical company, has shown a positive trend in its stock performance on September 30, 2024. The stock gained 7.02%, outperforming the sector by 6.35%. This marks the second consecutive day of gains for the company, with a total increase of 8.25%. Amrutanjan Health Care has a strong presence in the Indian market and has consistently provided quality healthcare products for over a century.

Amrutanjan Health Care, a smallcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on August 28, 2024. The stock has outperformed the sector by 1.58% and has shown consecutive gains for the past three days. It is currently trading above its moving averages, indicating a positive trend.

Amrutanjan Health Care, a smallcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on August 27, 2024. The stock has been performing well, outperforming the sector by 3.49% and showing consecutive gains for the past two days. It is also trading higher than its moving averages, indicating a positive trend.

Amrutanjan Health Care, a smallcap pharmaceutical company, has reported negative financial results for the quarter ending June 2024. The company's PBT and PAT have decreased significantly, while its operating profit margin and EPS have reached their lowest points in the last five quarters. Non-operating income is high, indicating an unsustainable source of income. MarketsMOJO has given a 'Hold' call for the company's stock.

Amrutanjan Health Care, a smallcap pharma company, has received an upgraded 'Buy' rating from MarketsMOJO. The company has shown high management efficiency with a ROE of 20.02% and a low Debt to Equity ratio. In the latest quarter, it reported positive results with a growth in PAT and NET SALES. Technical indicators also suggest a bullish trend. However, the stock is currently trading at a premium and has underperformed the market in the last year. Investors should carefully consider the risks before investing.

Amrutanjan Health Care, a smallcap pharmaceutical company, has been downgraded to a 'Hold' by MarketsMOJO due to its high management efficiency, positive financial performance, and technical indicators. However, its poor long-term growth and underperformance in the market have led to the downgrade. Investors are advised to hold their positions and monitor the company's performance closely.

Amrutanjan Health Care, a smallcap pharma company, has shown strong performance in the first quarter of 2024 with a growth of 32.89% in PAT (HY), 26.65% in NET SALES (Q), and 25.75% in PBT LESS OI (Q). The company's stock has been upgraded to 'Buy' by MarketsMOJO and is currently in a bullish trend, making it a potential investment option.

Amrutanjan Health Care, a smallcap pharmaceutical company, has been downgraded to a 'Hold' by MarketsMOJO due to its current performance and premium valuation. The company has shown high management efficiency and positive financial results, but its poor long-term growth and overvalued stock may be a concern for investors. Institutional investors have shown confidence in the company, but it is advised to monitor its performance closely.

Amrutanjan Health Care Ltd, a smallcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high of Rs. 826 on July 1st. With a 'Buy' call from MarketsMOJO and outperforming the sector, the company's stock shows potential for growth and has attracted high investor interest.

Amrutanjan Health Care Ltd, a smallcap pharmaceutical company, has gained 7.31% on July 1st, outperforming the sector by 7.77%. The stock has hit a new 52-week high of Rs. 826, with a 'Buy' call from MarketsMOJO. Despite high volatility, the stock has consistently traded above its moving averages, indicating strong performance and potential for growth.

On June 5th, 2024, Amrutanjan Health Care's stock price increased by 9.0%, outperforming the overall sector by 2.09%. The stock had been declining for four days, but today's gain could indicate a reversal. Moving averages are higher, and the stock has outperformed the Sensex by 2.71% in the past day. MarketsMOJO suggests a 'Hold' call for investors.

Amrutanjan Healt, a smallcap pharma company, has reported a positive financial performance for the quarter ended Mar 2024. The company's PAT has increased by 32.89% year on year, while net sales have grown by 26.65%. MarketsMOJO has given a 'Buy' call for the company's stock, indicating potential growth in the pharma industry.

Amrutanjan Health Care Ltd, a smallcap pharmaceutical company, has been gaining attention in the stock market with its recent performance. Its stock price reached a 52-week high of Rs. 802.6 on May 3rd, 2024, and has outperformed the sector by 0.41%. The company's strong performance and growth potential make it a promising investment opportunity in the pharmaceutical industry.

Amrutanjan Health Care, a smallcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on May 2nd, 2024. The stock has consistently outperformed the sector and has shown a remarkable growth of 27.21% in the past year. With a positive outlook and strong fundamentals, it presents a promising investment opportunity in the growing healthcare industry.

Amrutanjan Health Care Ltd, a smallcap pharmaceutical company, has gained 8.2% on May 2nd, 2024, closing at Rs 741.55. Its stock is currently just 4.68% away from its 52-week high and has outperformed the sector by 5.5%. The company's moving averages and impressive growth make it a promising player in the stock market.